{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:11:33Z","timestamp":1757614293861,"version":"3.44.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to investigate the relationship between endometrial thickness (EMT) on human chorionic gonadotropin (hCG) day in the progestin-primed ovarian stimulation (PPOS) protocol and pregnancy outcomes in the subsequent frozen\u2013thawed embryo transfer (FET) cycles, providing new insights into embryo transfer strategies for patients undergoing the PPOS protocol.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective study included 1,748 patients who underwent the PPOS protocol. Patients were divided into two groups based on the EMT on the hCG day: group A (EMT &amp;lt; 8\u00a0mm) and group B (EMT \u2265 8\u00a0mm). After 1:1 propensity score matching (group A: <jats:italic>n<\/jats:italic>\u00a0=\u00a0701; group B: <jats:italic>n<\/jats:italic>\u00a0=\u00a0701), the biochemical pregnancy, clinical pregnancy, and ongoing pregnancy rates were compared. In addition, the pregnancy outcomes under different endometrial preparation protocols were analyzed within each group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>(1) In groups A and B, the biochemical pregnancy rates were 44.5% and 45.5% (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.707), the clinical pregnancy rates were 38.5% and 42.5% (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.128), and the ongoing pregnancy rates were 29.1% and 34.2% (<jats:italic>p<\/jats:italic>\u00a0=\u00a00.039), respectively. For the cleavage-stage embryo transfers, groups A and B showed no significant differences in the biochemical pregnancy (39.5% <jats:italic>vs<\/jats:italic>. 35%, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.285), clinical pregnancy (35.9% <jats:italic>vs<\/jats:italic>. 30.5%, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.192), and ongoing pregnancy rates (26.8% <jats:italic>vs<\/jats:italic>. 24.4%, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.527). For blastocyst transfers, the biochemical pregnancy (47.8% vs.51.2%, <jats:italic>p<\/jats:italic> = 0.307) was similar, but,  clinical pregnancy (40.2% vs. 49%, <jats:italic>p<\/jats:italic> = 0.009), and ongoing pregnancy rates (30.6% vs. 39.6%, <jats:italic>p<\/jats:italic> = 0.005) were significantly higher in group B. (2) In group A, the endometrial preparation protocols had no statistically significant effect on the pregnancy outcomes. However, the natural cycles showed potentially better results (biochemical pregnancy rate, 43.1%; clinical pregnancy rate, 40.0%; and ongoing pregnancy rate, 34.1%) than hormone replacement therapy (HRT) (44.1%, 38.6%, and 29.9%, respectively), gonadotrophin-releasing hormone agonist plus HRT (GnRH-a+HRT) (45.1%, 39.3%, and 26.3%, respectively), and the mild stimulation cycles (27.8%, 16.7%, and 11.1%, respectively). In group B, patients using the GnRH-a+HRT protocol showed higher biochemical pregnancy (53.5%, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.022), clinical pregnancy (48.7%, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.096), and ongoing pregnancy rates (40.4%, <jats:italic>p<\/jats:italic>\u00a0=\u00a00.032) compared with those on natural cycles (38.2%, 33.9%, and 25.2%, respectively), HRT (42.9%, 40.8%, and 33.8%, respectively), and the mild stimulation protocol (45.5%, 45.5%, and 27.3%, respectively).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The EMT on the hCG day in the PPOS cycle was positively related to the pregnancy outcomes of subsequent FET, with EMT \u22658 mm associated with better pregnancy outcomes, particularly in patients undergoing blastocyst transfers.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1577872","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T05:32:41Z","timestamp":1757050361000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Study on the relationship between endometrial thickness on the hCG day in the progestin-primed ovarian stimulation protocol and pregnancy outcomes in frozen\u2013thawed embryo transfer cycles"],"prefix":"10.3389","volume":"16","author":[{"given":"Yutong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yajie","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","article-title":"Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization","volume":"104","author":"Kuang","year":"2015","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S226414","article-title":"Comparison between ppos and gnrha-long protocol in clinical outcome with the first ivf\/icsi cycle: a randomized clinical trial","volume":"12","author":"Xi","year":"2020","journal-title":"Clin Epidemiol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.744968","article-title":"Luteinizing hormone suppression by progestin-primed ovarian stimulation is associated with higher implantation rate for patients with polycystic ovary syndrome who underwent in vitro fertilization\/intracytoplasmic sperm injection cycles: comparing with short protocol","volume":"12","author":"Chen","year":"2021","journal-title":"Front Physiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2021.100540","article-title":"A comprehensive evaluation of progestin-primed ovarian stimulation protocol in patients with or without pcos undergoing in vitro fertilization","volume":"21","author":"Zhu","year":"2021","journal-title":"Reprod Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00796","article-title":"Progestin vs. Gonadotropin-releasing hormone antagonist for the prevention of premature luteinizing hormone surges in poor responders undergoing in vitro fertilization treatment: a randomized controlled trial","volume":"10","author":"Chen","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1004-3845.2017.05.013","article-title":"Comparison of outcome between progestin-primed ovarian stimulation protocol and long down-regulation protocol in different age groups of ivf with donor sperm","volume":"26","author":"Xin","year":"2017","journal-title":"J Reprod Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S263138","article-title":"Live-birth outcomes and congenital malformations after progestin-primed ovarian stimulation in maternal endometriosis","volume":"14","author":"Liang","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmy044","article-title":"Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis","volume":"25","author":"Craciunas","year":"2019","journal-title":"Hum Reprod Update"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu011","article-title":"Endometrial thickness and pregnancy rates after ivf: a systematic review and meta-analysis","volume":"20","author":"Kasius","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2023.103259","article-title":"A critical appraisal of studies on endometrial thickness and embryo transfer outcome","volume":"47","author":"Mathyk","year":"2023","journal-title":"Reprod BioMed Online"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.788706","article-title":"The effects of endometrial thickness on pregnancy outcomes of fresh ivf\/icsi embryo transfer cycles: an analysis of over 40,000 cycles among five reproductive centers in China","volume":"12","author":"Xu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145703","article-title":"The impact of endometrial thickness on the day of human chorionic gonadotrophin (hcg) administration on ongoing pregnancy rate in patients with different ovarian response","volume":"10","author":"Bu","year":"2015","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoad028","article-title":"The thicker the endometrium, the better the neonatal outcomes","volume":"2023","author":"Wu","year":"2023","journal-title":"Hum Reprod Open"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0529-567x.2018.11.003","article-title":"Relationship between endometrial thickness and pregnancy outcomes based on frozen-thawed embryo transfer cycles","volume":"53","author":"Huanfei","year":"2018","journal-title":"Chin J Obstetrics Gynecology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.19538\/j.fk2019030116","article-title":"Of endometrial thickness on the day of hcg administration on pregnancy outcome in the fresh ivf\/icsi cycle-a retrospective multicenter study","volume":"35","author":"Jiao","year":"2019","journal-title":"Chin J Pract Gynecology Obstetrics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"S0015","DOI":"10.1016\/j.fertnstert.2025.04.032","article-title":"Increasing Endometrial Thickness up to 12mm Is Associated with Increased Odds of Live Birth Among Fresh and Frozen-Thawed Autologous Transfers with or without PGT","author":"Gingold","year":"2025","journal-title":"Fertil Steril"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05939-y","article-title":"Effectiveness of progesterone-primed ovarian stimulation in assisted reproductive technology: a systematic review and meta-analysis","volume":"303","author":"Cui","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.fertnstert.2021.12.025","article-title":"Optimal endometrial thickness in fresh and frozen-thaw in vitro fertilization cycles: an analysis of live birth rates from 96,000 autologous embryo transfers","volume":"117","author":"Mahutte","year":"2022","journal-title":"Fertil Steril"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1448138","article-title":"The embryo stage at fresh ET does not affect the cumulative live birth rate in women with a thin endometrium: a retrospective matched-controlled cohort study","volume":"15","author":"Han","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh183","article-title":"Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles","volume":"19","author":"El-Toukhy","year":"2004","journal-title":"A randomised study Hum Reprod"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.09.015","article-title":"Cryopreserved-thawed embryo transfer in natural or down-regulated hormonally controlled cycles: a retrospective study","volume":"85","author":"Gelbaya","year":"2006","journal-title":"Fertil Steril"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-019-05065-4","article-title":"Different progestin-primed ovarian stimulation protocols in infertile women undergoing in vitro fertilization\/intracytoplasmic sperm injection: an analysis of 1188 cycles","volume":"299","author":"Guo","year":"2019","journal-title":"Arch Gynecol Obstet"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S230129","article-title":"Progestin-primed ovarian stimulation with dydrogesterone versus medroxyprogesterone acetate in women with polycystic ovarian syndrome for in vitro fertilization: a retrospective cohort study","volume":"13","author":"Huang","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex367","article-title":"New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for ivf: a randomized controlled trial including 516 first ivf\/icsi cycles","volume":"33","author":"Yu","year":"2018","journal-title":"Hum Reprod"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1577872\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T05:36:43Z","timestamp":1757050603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1577872\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":24,"alternative-id":["10.3389\/fendo.2025.1577872"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1577872","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"article-number":"1577872"}}